Bioverge is a venture capital firm specializing in emerging healthcare startups
Bioverge is a venture capital firm specializing in emerging healthcare startups. The firm operates Bioverge.com, an investment platform that aims to democratize access to startups solving healthcare’s biggest challenges and accelerate their progress.
Date
Company Name
|
Round | Money Raised | Industry | Lead Investor |
---|---|---|---|---|
May 9, 2022
Aspen Neuroscience
|
Series B | $147.50M | Biotechnology | — |
Sep 13, 2021
NutriSense
|
Seed | $3.80M | Apps | — |
Jun 15, 2021
Enveda Biosciences
|
Series A | — | Biotechnology | — |
May 25, 2021
Juno Diagnostics
|
Series A | — | Biotechnology | — |
Oct 24, 2017
Ligandal
|
Seed | — | Biotechnology | — |